Literature DB >> 2473416

Detailed immunoautoradiographic mapping of enkephalinase (EC 3.4.24.11) in rat central nervous system: comparison with enkephalins and substance P.

H Pollard1, M L Bouthenet, J Moreau, E Souil, P Verroust, P Ronco, J C Schwartz.   

Abstract

The metallopeptidase enkephalinase known to participate in the inactivation of endogenous enkephalins and, possibly, other neuropeptides such as tachykinins, was visualized by autoradiography using a [125I]iodinated monoclonal antibody. A detailed mapping of the enzyme in rat brain and spinal cord was established on 10-micron serial sections prepared in a frontal plane as well as a few sections in a sagittal plane. On adjacent sections, and for the purpose of comparison, substance P-like and enkephalin-like immunoreactivities were also visualized by autoradiography using a 125I-monoclonal antibody and a polyclonal antibody detected by a secondary 125I-anti-rabbit antibody respectively. Histological structures were identified on adjacent Nissl-stained sections. Using the highly sensitive 125I-probe, enkephalinase immunoreactivity was found to be distributed in a markedly heterogeneous manner in all areas of the central nervous system. Immunoreactivity was undetectable in white matter areas, for example the corpus callosum or fornix, and had a laminar pattern in, for example, the cerebral cortex or hippocampal formation. Hence, although immunodetection was not performed at the cellular level, a major neuronal localization of the peptidase is suggested. The latter is consistent with the detection of a strong immunoreactivity in a pathway linking the striatum to the globus pallidum, the entopeduncular nucleus and the substantia nigra, as well as with a series of biochemical and lesion data. The strong immunoreactivity also present in choroid plexuses and ependymal cells as well as in the intermediate lobe and in scattered cells of the anterior lobe of the pituitary suggests that populations of glial and endocrine cells also express the peptidase. The highest density of enkephalinase immunoreactivity was observed in basal ganglia and limbic areas (caudate putamen, globus pallidus, nucleus accumbens, olfactory tubercles) as well as in areas involved in pain control mechanisms (superficial layers of the spinal nucleus of the trigeminal nerve or of the dorsal horn of the spinal cord) which also display the highest immunoreactivities for both enkephalins and substance P (except in globus pallidus for the latter). These localizations account for the opioid-like analgesic and motor effects of enkephalinase inhibitors inasmuch as a selective or predominant participation of the peptidase in enkephalin inactivation is assumed. A number of other areas appear richly endowed in both enkephalinase and enkephalins whereas substance P is hardly detectable. This is particularly the case for the olfactory bulb, bed nucleus of the accessory olfactory tract, the cerebellum (where enkephalinase mainly occurs in the molecular layer) and the hippocampal formation (namely in the molecular layer of the dentate gyrus).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473416     DOI: 10.1016/0306-4522(89)90258-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

Review 1.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

Authors:  S K Böhm; E F Grady; N W Bunnett
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

2.  Neutral endopeptidase (EC 3.4.24.11) in labial salivary glands in healthy controls and in patients with Sjögren's syndrome.

Authors:  Y T Konttinen; J Törnwall; P Kemppinen; H Uusitalo; T Sorsa; M Hukkanen; J M Polak
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

3.  Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old question.

Authors:  Richard E Kast
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

4.  Expression of cALLa/NEP on gliomas: a possible marker of malignancy.

Authors:  L Monod; M F Hamou; P Ronco; P Verroust; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

5.  Interactions between neutral endopeptidase (EC 3.4.24.11) and the substance P (NK1) receptor expressed in mammalian cells.

Authors:  A Okamoto; M Lovett; D G Payan; N W Bunnett
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

6.  Developmental Profile of Brain Neprilysin Expression Correlates with Olfactory Behaviour of Rats.

Authors:  Dimitrii S Vasilev; Nadezhda M Dubrovskaya; Igor A Zhuravin; Natalia N Nalivaeva
Journal:  J Mol Neurosci       Date:  2021-01-12       Impact factor: 3.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.